Giuseppe Cancello

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 533 citations

Surgical Oncology, Breast Oncology, Medicine +7

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer

Giuseppe Cancello, Patrick Maisonneuve, Nicole Rotmensz et al. · Annals of Oncology · 2010 · 236 citations · Full text

Surgical Oncology, Oncology, Adjuvant Treatment Effects +8

Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome

Emilia Montagna, Patrick Maisonneuve, Nicole Rotmensz et al. · Clinical Breast Cancer · 2012 · 151 citations · Full text

Breast Oncology, Medicine, Surgical Pathology +7

Outcome of special types of luminal breast cancer

Marco Colleoni, Nicole Rotmensz, Patrick Maisonneuve et al. · Annals of Oncology · 2011 · 122 citations · Full text

Breast Oncology, Medicine, Pathology +5

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse

Giuseppe Cancello, Patrick Maisonneuve, Nicole Rotmensz et al. · Annals of Oncology · 2012 · 122 citations

Tumor Biology, Higher Risk, Breast Oncology +10